Human cholesteryl ester transfer protein measured by enzyme-linked immunosorbent assay with two monoclonal antibodies against rabbit cholesteryl ester transfer protein: Plasma cholesteryl ester transfer protein and lipoproteins among japanese hypercholesterolemic patients

Clinical Chemistry

Volumn 44, Issue 7, 1998, Pages 1466-1473

  Sasai, Kanna ^a   Okumura Noji, Kuniko ^a   Hibino, Takeshi ^a   Ikeuchi, Reiko ^a   Sakuma, Nagahiko ^a   Fujinami, Takao ^a   Yokoyama, Shinji ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCLONAL ANTIBODY; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE;

ORYCTOLAGUS CUNICULUS;

EID: 0031832552     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.7.1466     Document Type: Article

References (49)

1. Morton RE:, Zilversmit DB. Inter-relationship of lipids transferred by the lipid-transfer protein isolated from human lipoprotein-deficient plasma. J Biol Chem l983;258:11751.-7.
2. Hesler CB, Tall AR, Swenson TL, Weech PK, Marcel YL, Milne RW. Monoclonal antibodies to the Mr 74,000 cholesteryl ester transfer protein neutralize all of the cholesteryl ester and triglyceride transfer activities in human plasma. J Biol Chem 1988:263: 5020-3.
3. Tall AR. Plasma cholesteryl ester transfer protein. J Lipid Res 1993:34:1255-74.
4. Glomset JA. The plasma lecithin:cholesterol acyltransferase reaction. J Lipid Res 1968;9:155-67.
5. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986;232:34-47.
6. Kozarsky KF, Donahee MH, Rigotti A, Iqbal SN, Edelman ER, Krieger M. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 1997;387:414-7.
7. Marotti KR, Castle CK, Boyle TP, Lin AH, Murray RW, Melchior GW. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 1993;364:73-5.
8. Hayek T, Masucci-Magoulas L, Jiang X, Walsh A, Rubin E, Breslow JL, et al. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J Clin Invest 1995;96:2071-4.
9. Zhong S, Sharp DS, Grove JS, Bruce C, Yano K, Curb JD, et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 1996;97:2917-23.
10. Hirano K, Yamashita S, Kuga Y, Sakai N, Nozaki S, Kihara S, et al. Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. Arterioscler Thromb Vasc Biol 1995; 15:1849-56.
11. Hirano K, Yamashita S, Nakajima N, Arai T, Maruyama T, Yoshida Y, et al. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. Arterioscler Thromb Vasc Biol 1997;17: 1053-9.
12. Ko KW, Oikawa K, Ohnishi T, Kay CM, Yokoyama S. Purification, characterization, and conformational analysis of rabbit plasma lipid transfer protein. Biochemistry 1993;32:6729-36.
13. Ko KW, Ohnishi T, Yokoyama S. Triglyceride transfer is required for net cholesteryl ester transfer between lipoproteins in plasma by lipid transfer protein. Evidence for a hetero-exchange transfer mechanism demonstrated by using novel monoclonal antibodies. J Biol Chem 1994:269:28206-13.
14. Ohnishi T, Yokoyama S, Yamamoto A. Rapid purification of human plasma lipid transfer proteins. J Lipid Res 1990;31:397-406.
15. Brown ML, Inazu A, Hesler CB, Agellon LB, Mann C, Whitlock ME, et al. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature 1989:342:448-51.
16. Nakane PK, Kawaoi A. Peroxidase-labeled antibody. A new method of conjugation. J Histochem Cytochem 1974;22:1084-91.
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
18. Albers JJ, Tollefson JH, Chen CH, Steinmetz A. Isolation and characterization of human plasma lipid transfer proteins. Arteriosclerosis 1984;4:49-58.
19. Yamashita S, Sprecher DL, Matsuzawa Y, Sakai N, Tarui S, Harmony JA, et al. A delayed-addition enzyme immunoassay for the relative cholesteryl ester transfer protein mass in patients with deficient plasma cholesteryl ester transfer activity. Clin Chim Acta 1990;194:145-59.
20. Marcel YL, McPherson R, Hogue M, Czarnecka H, Zawadzki Z, Weech PK, et al. Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects. J Clin Invest 1990:85:10-7.
21. Fukasawa M, Arai H, Inoue K. Establishment of anti-human cholesteryl ester transfer protein monoclonal antibodies and radioimmunoassaying of the level of cholesteryl ester transfer protein in human plasma. J Biochem 1992;111:696-8.
22. Ritsch A, Auer B, Foger B, Schwarz S, Patsch JR. Polyclonal antibody-based immunoradiometric assay for quantification of cholesteryl ester transfer protein. J Lipid Res 1993;34:673-9.
23. Mezdour H, Kora I, Parra HJ, Tartar A, Marcel YL, Fruchart JC. Two-site enzyme immunoassay of cholesteryl ester transfer protein with monoclonal and oligoclonal antibodies. Clin Chem 1994; 40:593-7.
24. Guyard-Dangremont V, Lagrost L, Gambert P, Lallemant C. Competitive enzyme-linked immunosorbent assay of the human cholesteryl ester transfer protein (CETP). Clin Chim Acta 1994;231:147-60.
25. Clark RW, Moberly JB, Bamberger MJ. Low level quantification of cholesteryl ester transfer protein in plasma subfractions and cell culture media by monoclonal antibody-based immunoassay. J Lipid Res 1995;36:876-89.
26. Sato T, Fukasawa M, Kinoshita M, Arai H, Saeki T, Naraki T, et al. Enzyme-linked immunosorbent assay for cholesteryl ester transfer protein in human serum. Clin Chim Acta 1995;240:1-9.
27. Sugano M, Makino N, Sawada S, Otsuka S, Watanabe M, Okamoto H, et al. Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis on cholesterol-fed rabbits. J Biol Chem 1998;273:5033-6.
28. Kinoshita M, Teramoto T, Shimazu N, Kaneko K, Ohta M, Koike T, et al. CETP is a determinant of serum LDL-cholesterol but not HDL-cholesterol in healthy Japanese. Atherosclerosis 1996;120:75-82.
29. Tato F, Vega GL, Tall AR, Grundy SM. Relation between cholesterol ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia. Arterioscler Thromb Vasc Biol 1995;15:112-20.
30. Homma Y, Ozawa H, Kobayashi T, Yamaguchi H, Sakane H, Nakamura H. Effects of simvastatin on plasma lipoprotein subfractions, cholesterol esterification rate, and cholesteryl ester transfer protein in type II hyperlipoproteinemia. Atherosclerosis 1995;114:223-34.
31. Carrilho AJ, Medina WL, Nakandakare ER, Quintao EC. Plasma cholesteryl ester transfer protein is lowered by treatment of hypercholesterolemia with cholestyramine. Clin Pharmacol Ther 1997;62:82-8.
32. Fielding CJ, Reaven GM, Liu G, Fielding PE. Increased free cholesterol in plasma low and very low density lipoproteins in non-insulin-dependent diabetes mellitus: its role in the inhibition of cholesteryl ester transfer. Proc Nat Acad Sci U S A 1984;81:2512-6.
33. Dullaart RP, Groener JE, Dikkeschei LD, Erkelens DW, Doorenbos H. Increased cholesteryl ester transfer activity in complicated type 1 (insulin-dependent) diabetes mellitus-its relationship with serum lipids. Diabetologia 1989;32:14-9.
34. Dieplinger H, Schoenfeld PY, Fielding CJ. Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis. J Clin Invest 1986; 77:1071-83.
35. Mendez AJ, Perez GO, Hsia SL. Defect in cholesteryl ester transport in serum of patients with uremia receiving maintenance hemodialysis: increased inhibitor activity for cholesteryl ester transfer. J Lab Clin Med 1988;111:677-83.
36. Koizumi J, Inazu A, Yagi K, Koizumi I, Uno Y, Kajinami K, et al. Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiency. Atherosclerosis 1991;90:189-96.
37. Akita H, Chiba H, Tsuchihashi K, Tsuji M, Kumagai M, Matsuno K, et al. Cholesteryl ester transfer protein gene: two common mutations and their effect on plasma high-density lipoprotein cholesterol content. J Clin Endocri Metab 1994;79:1615-8.
38. Foger B, Ritsch A, Doblinger A, Wessels H, Patsch JR. Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol. Studies in normotriglyceridemia and moderate hypertriglyceridemia. Arterioscler Thromb Vasc Biol 1996;16:1430-6.
39. Quinet E, Tall A, Ramakrishnan R, Rudel L. Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. J Clin Invest 1991;87:1559-66.
40. McPherson R, Hogue M, Milne RW, Tall AR, Marcel YL. Increase in plasma cholesteryl ester transfer protein during probucol treatment. Relation to changes in high density lipoprotein composition. Arterioscler Thromb 1991;11:476-81.
41. Chiesa G, Michelagnoli S, Cassinotti M, Gianfranceschi G, Werba JP, Pazzucconi F, et al. Mechanisms of high-density lipoprotein reduction after probucol treatment: changes in plasma cholesterol esterification/transfer and lipase activities. Metabolism 1993; 42:229-35.
42. Hannuksela M, Marcel YL, Kesaniemi YA, Savolainen MJ. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res 1992;33:737-44.
43. Hirano K, Matsuzawa Y, Sakai N, Hiraoka H, Nozaki S, Funahashi T, et al. Polydisperse low-density lipoproteins in hyperalphalipoproteinemic chronic alcohol drinkers in association with marked reduction of cholesteryl ester transfer protein activity. Metabolism 1992;41:1313-8.
44. Freeman DJ, Griffin BA, Murray E, Lindsay GM, Gaffney D, Packard CJ, et al. Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution. Eur J Clin Invest 1993;23:630-40.
45. Dullaart RP, Hoogenberg K, Dikkeschei BD, van Tol A. Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men. Arterioscler Thromb 1994;14:1581-5.
46. Silliman K, Tall AR, Kretchmer N, Forte TM. Unusual high-density lipoprotein subclass distribution during late pregnancy. Metabolism 1993;42:1592-9.
47. Iglesias A, Montelongo A, Herrera E, Lasuncion MA. Changes in cholesteryl ester transfer protein activity during normal gestation and postpartum. Clin Biochem 1994;27:63-8.
48. Dullaart RP, Sluiter WJ, Dikkeschei LD, Hoogenberg K, van Tol A. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest 1994;24:188-94.
49. Arai T, Yamashita S, Hirano K, Sakai N, Kotani K, Fujioka S, et al. Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity. Arterioscler Thromb 1994;14: 1129-36.